A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-κB activities

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1198-1206

  Chen, Jun ^a,b   Giridhar, Karthik V ^a   Zhang, Liyong ^a   Xu, Shuping ^a   Jane Wang, Q ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; POLYCYSTIN 1; POLYCYSTIN 2; PROTEASOME; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C GAMMA; PROTEIN KINASE D; UBIQUITIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN LNCAP; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 79961194947     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr113     Document Type: Article

References (46)

1. Barry,O.P. et al. (2001) Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr. Pharm. Des., 7, 1725-1744.
2. Gonzalez-Guerrico,A.M. et al. (2005) Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells. J. Biochem. Mol. Biol., 38, 639-645.
3. Xiao,L. et al. (2008) Phorbol ester-induced apoptosis and senescence in cancer cell models. Methods Enzymol., 446, 123-139.
4. Zhang,W. et al. (2005) Protein kinase D specifically mediates apoptosis signal-regulating kinase 1-JNK signaling induced by H2O2 but not tumor necrosis factor. J. Biol. Chem., 280, 19036-19044.
5. Schaar,D. et al. (2006) A phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies. Cancer Chemother. Pharmacol., 57, 789-795.
6. Griner,E.M. et al. (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer, 7, 281-294.
7. Newton,A.C. (2001) Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev., 101, 2353-2364.
8. Gavrielides,M.V. et al. (2006) Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells. Cancer Res., 66, 11792-11801.
9. Fujii,T. et al. (2000) Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. J. Biol. Chem., 275, 7574-7582.
10. Garcia-Bermejo,M.L. et al. (2002) Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha. J. Biol. Chem., 277, 645-655.
11. Gonzalez-Guerrico,A.M. et al. (2005) Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase C delta. J. Biol. Chem., 280, 38982-38991.
12. Tanaka,Y. et al. (2003) Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem., 278, 33753-33762.
13. Xiao,L. et al. (2009) ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK. J. Biol. Chem., 284, 29365-29375.
14. Xiao,L. et al. (2009) PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens. Mol. Carcinog., 48, 187-195.
15. Thakkar,H. et al. (2001) Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance. J. Biol. Chem., 276, 38361-38369.
16. Chen,X. et al. (2001) Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene, 20, 6073-6083.
17. Manning,G. et al. (2002) The protein kinase complement of the human genome. Science, 298, 1912-1934.
18. Johannes,F.J. et al. (1994) PKCu is a novel, atypical member of the protein kinase C family. J. Biol. Chem., 269, 6140-6148.
19. Valverde,A.M. et al. (1994) Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl Acad. Sci. USA, 91, 8572-8576.
20. Sturany,S. et al. (2001) Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J. Biol. Chem., 276, 3310-3318.
21. Hayashi,A. et al. (1999) PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu. Biochim. Biophys. Acta, 1450, 99-106.
22. Waldron,R.T. et al. (2003) Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J. Biol. Chem., 278, 154-163.
23. Zugaza,J.L. et al. (1996) Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO. J., 15, 6220-6230.
24. Wang,Q.J. (2006) PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol. Sci., 27, 317-323.
25. Rozengurt,E. et al. (2005) Protein kinase D signaling. J. Biol. Chem., 280, 13205-13208.
26. Sinnett-Smith,J. et al. (2007) Protein kinase D2 potentiates MEK/ERK/RSK signaling, c-Fos accumulation and DNA synthesis induced by bombesin in Swiss 3T3 cells. J. Cell. Physiol., 211, 781-790.
27. Sinnett-Smith,J. et al. (2004) Protein kinase D potentiates DNA synthesis induced by Gq-coupled receptors by increasing the duration of ERK signaling in swiss 3T3 cells. J. Biol. Chem., 279, 16883-16893.
28. Wong,C. et al. (2005) Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J. Biol. Chem., 280, 33262-33269.
29. Trauzold,A. et al. (2003) PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene, 22, 8939-8947.
30. Storz,P. et al. (2003) Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. Embo. J., 22, 109-120.
31. Bravo (2011) -Altamirano,K. et al. (2011) Synthesis and structure-activity relationships of benzothienothiazepinone inhibitors of protein kinase D. ACS Med. Chem. Lett., 2, 154-159.
32. Lavalle,C.R. et al. (2010) Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility. BMC Chem. Biol., 10, 5.
33. Sharlow,E.R. et al. (2008) Potent and selective disruption of protein kinase d functionality by a benzoxoloazepinolone. J. Biol. Chem., 283, 33516-33526.
34. Chen,J. et al. (2008) Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res., 68, 3844-3853.
35. Duriez,P.J. et al. (1997) Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol., 75, 337-349.
36. Trauzold,A. et al. (2001) CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene, 20, 4258-4269.
37. Busuttil,V. et al. (2002) Blocking NF-kappaB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector. Oncogene, 21, 3213-3224.
38. Wang,Q. et al. (2006) PKCdelta-mediated regulation of FLIP expression in human colon cancer cells. Int. J. Cancer, 118, 326-334.
39. Wang,Q. et al. (2003) Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B. J. Biol. Chem., 278, 51091-51099.
40. Yin,L. et al. (2005) Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway. J. Biol. Chem., 280, 5533-5541.
41. Zhimin,L. et al. (2009) Degradation of activated protein kinases by ubiquitination. Annu. Rev. Biochem., 78, 435-475.
42. Hochstrasser,M. (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol., 7, 215-223.
43. Lu,Z. et al. (1998) Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol., 18, 839-845.
44. Lee,H.W. et al. (1996) Ubiquitination of protein kinase C-alpha and degradation by the proteasome. J. Biol. Chem., 271, 20973-20976.
45. Feng,H. et al. (2006) Conserved domains subserve novel mechanisms and functions in DKF-1, a Caenorhabditis elegans protein kinase D. J. Biol. Chem., 281, 17815-17826.
46. Rennecke,J. et al. (1996) Immunological demonstration of protein kinase C mu in murine tissues and various cell lines. Differential recognition of phosphorylated forms and lack of down-regulation upon 12-O-tetradecanoylphorphol-13-acetate treatment of cells. Eur. J. Biochem., 242, 428-432.